RhumbLine Advisers’s Lifecore Biomedical LFCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$309K Buy
38,091
+13,361
+54% +$108K ﹤0.01% 2967
2025
Q1
$174K Sell
24,730
-30,993
-56% -$218K ﹤0.01% 3177
2024
Q4
$414K Buy
55,723
+31,056
+126% +$231K ﹤0.01% 2786
2024
Q3
$122K Sell
24,667
-2,232
-8% -$11K ﹤0.01% 3445
2024
Q2
$138K Buy
26,899
+25,378
+1,669% +$130K ﹤0.01% 3401
2024
Q1
$8.08K Hold
1,521
﹤0.01% 3905
2023
Q4
$9.41K Hold
1,521
﹤0.01% 3872
2023
Q3
$11.5K Sell
1,521
-1,637
-52% -$12.4K ﹤0.01% 3856
2023
Q2
$30.5K Sell
3,158
-38,804
-92% -$375K ﹤0.01% 3751
2023
Q1
$158K Buy
41,962
+647
+2% +$2.44K ﹤0.01% 2788
2022
Q4
$268K Buy
41,315
+614
+2% +$3.98K ﹤0.01% 2713
2022
Q3
$362K Buy
40,701
+2,820
+7% +$25.1K ﹤0.01% 2643
2022
Q2
$378K Buy
37,881
+1,471
+4% +$14.7K ﹤0.01% 2632
2022
Q1
$422K Sell
36,410
-3,120
-8% -$36.2K ﹤0.01% 2495
2021
Q4
$439K Sell
39,530
-59
-0.1% -$655 ﹤0.01% 2566
2021
Q3
$365K Buy
39,589
+756
+2% +$6.97K ﹤0.01% 2686
2021
Q2
$437K Sell
38,833
-7,056
-15% -$79.4K ﹤0.01% 2624
2021
Q1
$486K Sell
45,889
-100
-0.2% -$1.06K ﹤0.01% 2512
2020
Q4
$499K Buy
45,989
+5,437
+13% +$59K ﹤0.01% 2442
2020
Q3
$394K Sell
40,552
-6,152
-13% -$59.8K ﹤0.01% 2398
2020
Q2
$372K Buy
46,704
+3,576
+8% +$28.5K ﹤0.01% 2464
2020
Q1
$375K Buy
43,128
+1,643
+4% +$14.3K ﹤0.01% 2293
2019
Q4
$469K Buy
41,485
+82
+0.2% +$927 ﹤0.01% 2390
2019
Q3
$450K Buy
41,403
+3,146
+8% +$34.2K ﹤0.01% 2375
2019
Q2
$358K Sell
38,257
-1,050
-3% -$9.83K ﹤0.01% 2513
2019
Q1
$483K Buy
39,307
+884
+2% +$10.9K ﹤0.01% 2341
2018
Q4
$455K Buy
38,423
+11,792
+44% +$140K ﹤0.01% 2338
2018
Q3
$383K Hold
26,631
﹤0.01% 2386
2018
Q2
$397K Buy
26,631
+1,035
+4% +$15.4K ﹤0.01% 2407
2018
Q1
$334K Sell
25,596
-1,225
-5% -$16K ﹤0.01% 2387
2017
Q4
$338K Sell
26,821
-4,801
-15% -$60.5K ﹤0.01% 2404
2017
Q3
$410K Buy
31,622
+245
+0.8% +$3.18K ﹤0.01% 2409
2017
Q2
$466K Sell
31,377
-7,238
-19% -$107K ﹤0.01% 2342
2017
Q1
$463K Buy
38,615
+5,660
+17% +$67.9K ﹤0.01% 2283
2016
Q4
$455K Sell
32,955
-3,217
-9% -$44.4K ﹤0.01% 2278
2016
Q3
$485K Buy
36,172
+240
+0.7% +$3.22K ﹤0.01% 2225
2016
Q2
$387K Sell
35,932
-5,993
-14% -$64.5K ﹤0.01% 2371
2016
Q1
$440K Buy
41,925
+3,300
+9% +$34.6K ﹤0.01% 2301
2015
Q4
$457K Buy
38,625
+2,755
+8% +$32.6K ﹤0.01% 2300
2015
Q3
$419K Buy
35,870
+1,793
+5% +$20.9K ﹤0.01% 2349
2015
Q2
$492K Sell
34,077
-4,525
-12% -$65.3K ﹤0.01% 2342
2015
Q1
$538K Buy
38,602
+2,000
+5% +$27.9K ﹤0.01% 2263
2014
Q4
$505K Buy
36,602
+3,200
+10% +$44.2K ﹤0.01% 2269
2014
Q3
$409K Hold
33,402
﹤0.01% 2338
2014
Q2
$417K Buy
33,402
+9,575
+40% +$120K ﹤0.01% 2390
2014
Q1
$266K Sell
23,827
-1,170
-5% -$13.1K ﹤0.01% 2607
2013
Q4
$303K Hold
24,997
﹤0.01% 2585
2013
Q3
$305K Buy
24,997
+39
+0.2% +$476 ﹤0.01% 2513
2013
Q2
$330K Buy
+24,958
New +$330K ﹤0.01% 2575